The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
Clinical trial NCT05536466 · UNKNOWN
Trial details
- NCT number
- NCT05536466
- Sponsor
- Radboud University Medical Center
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2023-07-23
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.